Health ❯ Healthcare ❯ Clinical Research

Phase 3 Trials

Randomized Controlled Trials HOPE-3 Trial Patient Outcomes OASIS Trials Purpose Studies EULAR 2025 CORE and CORE2 Trials Eli Lilly's Orforglipron ATTAIN-1 Trial Combination Therapy Weight Loss Medications MajesTEC-3 Study STEER and STRENGTH Studies Efficacy Studies STEP UP Trial Novo Nordisk SOUL Trial GRACE Trial Pirtobrutinib

FDA Issues Complete Response Letter for Corcept’s Relacorilant in Cushing’s-Related Hypertension

The agency requested additional evidence of effectiveness to support a favorable benefit–risk assessment.

Roche’s Giredestrant Cuts Early Breast Cancer Recurrence 30% in Phase III Trial

FDA Approves One-Time Intrathecal Gene Therapy Itvisma for Older SMA Patients

J&J Myeloma Trial Stopped Early After Tecvayli–Darzalex Shows PFS and OS Benefit

FDA Opens Door to Reconsider Capricor’s Duchenne Cell Therapy Based on HOPE-3 Data

Ionis’ Olezarsen Slashes Triglycerides, Cuts Pancreatitis in Phase 3 Trials

Moderna Withdraws Flu-COVID Vaccine Application After FDA Requests More Data